PEREGRINE PHARMACEUTICALS INC·4

May 2, 8:19 PM ET

PEREGRINE PHARMACEUTICALS INC 4

4 · PEREGRINE PHARMACEUTICALS INC · Filed May 2, 2016

Insider Transaction Report

Form 4
Period: 2016-04-29
KING STEVEN W
DirectorPresident & CEO
Transactions
  • Other

    Common Stock

    2016-04-29$0.30/sh+10,683$3,216193,963 total
Footnotes (1)
  • [F1]Shares acquired under the issuer's employee stock purchase plan on April 29, 2016.

Documents

1 file
  • 4
    king_f4-042916.xmlPrimary

    OWNERSHIP DOCUMENT